TIL · Instil Bio, Inc. · Executive Compensation
$6.95
-0.27 (-3.74%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 13, 2026
The latest filing states the doubt was alleviated.
“As discussed above and in Note 10 to the accompanying condensed consolidated financial statements, the 2024 Loan is due in January 2027, for total principal of $85.6 million, which is in excess of cash, cash equivalents, and marketable securities on hand as of June 30, 2026, which we concluded is an indicator of substantial doubt about our ability to continue as a going concern. We concluded that management's plans, including Complex Therapeutics LLC's contractual right to exercise the extension option to January 2028, which is within Complex Therapeutics LLC's control, alleviate the conditions that raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$48.63M
Shares
6.78M
Volume · Oct 5
12.94K
Avg daily vol (3M)
11.8K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Bronson Crouch | Chief Executive Officer and Chairman | $2,256,412 |
| Sandeep Laumas | Chief Financial Officer and Chief Business Officer | $1,235,987 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Bronson Crouch | Chief Executive Officer and Chairman | $5,323,858 |
| Sandeep Laumas | Chief Financial Officer and Chief Business Officer | $4,079,428 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Bronson Crouch | Chief Executive Officer and Chairman | $1,558,881 |
| Sandeep Laumas | Chief Financial Officer and Chief Business Officer | $904,510 |
| Sumita Ray | — | $730,142 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Bronson Crouch | Chief Executive Officer and Chairman | $4,892,017 |
| Timothy Moore | Former Chief Operating Officer | $3,399,296 |
| Former Chief Legal | Compliance and Administrative Officer | $2,810,080 |
| Sumita Ray | — | $2,810,080 |
| Vijay Chiruvolu | Former Chief Technical Officer | $2,550,072 |
| Sandeep Laumas | Chief Financial Officer and Chief Business Officer | $1,805,670 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Bronson Crouch | Chief Executive Officer and Chairman | $35,775,826 |
| Vijay Chiruvolu | Former Chief Technical Officer | $12,123,652 |
| Zachary Roberts | Chief Medical Officer | $6,939,882 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Bronson Crouch | Chief Executive Officer and Chairman | $5,733,683 |
| Zachary Roberts | Chief Medical Officer | $2,195,754 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jack B. Nielsen | Board of Directors | Resigned | 2024-04-26 |
| Vijay Chiruvolu, Ph.D. | Chief Technical Officer | Resigned | 2022-09-06 |
| Timothy L. Moore | Chief Operating Officer | Appointed | 2022-09-06 |